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Glucose ingestion afteran overnightfast triggersan insulin-dependent, homeostaticprogram thatis
altered in diabetes. The full spectrum of biochemical changes associated with this transition is
currently unknown. We have developed a mass spectrometry-based strategy to simultaneously
measure 191 metabolites following glucose ingestion. In two groups of healthy individuals (n¼22
and 25), 18 plasma metabolites changed reproducibly, including bile acids, urea cycle
intermediates, and purine degradation products, none of which were previously linked to glucose
homeostasis. The metabolite dynamics also revealed insulin’s known actions along four key axes—
proteolysis, lipolysis, ketogenesis, and glycolysis—reﬂecting a switch from catabolism to
anabolism. In pre-diabetics (n¼25), we observed a blunted response in all four axes that correlated
with insulin resistance. Multivariate analysis revealed that declines in glycerol and leucine/iso-
leucine (markers of lipolysis and proteolysis, respectively) jointly provide the strongest predictor of
insulinsensitivity.Thisobservationindicatesthatsomehumansareselectivelyresistanttoinsulin’s
suppressionofproteolysis, whereasothers,to insulin’ssuppression oflipolysis.Ourﬁndings laythe
groundwork for using metabolic proﬁling to deﬁne an individual’s ‘insulin response proﬁle’, which
could have value in predicting diabetes, its complications, and in guiding therapy.
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Introduction
Glucose homeostasis is a complex physiologic process invol-
ving the orchestration of multiple organ systems. During an
overnight fast, for instance, glucose levels are maintained
through both glycogenolysis and gluconeogenesis, and the
liver begins to generate ketone bodies (e.g. acetoacetate,
b-hydroxybutyrate) from fatty acids released byadipose tissue
(Cahill, 2006). Ingestion of glucose afterovernight fasting then
triggers the rapid release of insulin from the pancreas, which
promotes glucose uptake in peripheral tissues and switches
the body from catabolism to anabolism. For example,
proteolysis in skeletal muscle and associated release of amino
acids (which support gluconeogenesis) arereplaced byamino-
acid uptake and proteinsynthesis(Felig, 1975; Fukagawa et al,
1985). Also, triacylglycerol lysis in adipose tissue and hepatic
synthesis of ketone bodies are inhibited and replaced by fatty
acid uptake and re-esteriﬁcation. Hence the transition from
fasting to feeding is accompanied by many changes in
metabolite concentrations as the body makes adjustments to
achieve glucose homeostasis.
To obtain a systematic view of the physiologic response to
glucose ingestion in health and disease, we wished to
simultaneously monitor the concentrations of a large and
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in the classiﬁcation of metabolic states, reveal new pathways,
and potentially improve the sensitivity for detection of
abnormalities. Traditionally, single metabolites or classes
of small molecules have been detected using dedicated
analytical assays. With these methods, relationships among
diverse metabolites and pathways have been missed, and a
comprehensive picture of a complex physiologic program has
not been possible. Such relationships could, in principle, be
importantinunderstandingdiseasepathogenesisandinaiding
in the diagnosis of disease.
Recent advances in analytical chemistry and computation
now enable the simultaneous measurement of a large number
of metabolites. Two technologies are commonly used for
metabolic proﬁling: nuclear magnetic resonance (NMR)
spectroscopy and mass spectrometry (MS) (Dunn et al,
2005). Although NMR spectroscopy has a number of advan-
tages, primarily its non-destructive nature, its ability to
provide information on chemical structure and its better
suitability for absolute quantiﬁcation, it tends to have low
sensitivity.MStechnology,on theotherhand, affordssensitive
and speciﬁc analysis of metabolites in complex biological
samples, particularly when implemented as tandem MS and
coupledwithhigh-performanceliquidchromatography(LC),a
combination termed LC-MS/MS. Metabolic proﬁling with LC-
MS/MS technology has already been successfully used for
identifying human plasma markers of myocardial ischemia
(Sabatine et al, 2005) as well as for characterizing the
metabolic response to starvation in model organisms (Brauer
et al, 2006).
We have developed an LC-MS/MS metabolic proﬁling
system capable of quantifying metabolites in plasma (see
Materials and methods), and we report here its application to
studying the human response to an oral glucose load. Our
system can measure 191 endogenous human metabolites
spanning diverse chemical classes (Supplementary informa-
tion). This collection of metabolites includes those previously
studied in the context of glucose homeostasis, as well as many
metabolites not previously linked to this area. We ﬁrst applied
this technology to healthy individuals to characterize the
normal humanresponseto anoral glucose challenge, and then
asked how this response is affected by reduced insulin
sensitivity in individuals with impaired glucose tolerance.
Results
Eighteen plasma metabolites change signiﬁcantly
and reproducibly during an oral glucose challenge
To systematically characterize the normal biochemical
response to glucose ingestion in humans, we obtained plasma
samples for metabolic proﬁling from an ongoing study,
Metabolic Abnormalities in College Students (MACS, see
Materials and methods). In this study, young adults undergo
aseriesof metabolicevaluations,includinga questionnairefor
metabolic syndrome risk factors, indirect calorimetry, mea-
surement of body composition, and a fasting blood lipid
proﬁle. As part of the metabolic assessment, MACS subjects
also undergo a 2-h oral glucose tolerance test (OGTT) with
multiple blood draws. To control for the fasting condition and
for the effects of ﬂuid ingestion, a subset of MACS subjects
selected at random were given an identical volume of water
instead of the glucose solution. Venous blood was drawn
during fasting and then every 30min following glucose or
water ingestion for the 2-h duration of the test. We obtained
samples from 22 subjects ingesting glucose and 7 control
subjects ingesting water (Table I). Serum concentrations of
glucose and insulin were measured throughout the test
(Figure 1A). All subjects had normal fasting glucose levels,
and all glucose-ingesting subjects showed normal glucose
tolerance, as currently deﬁned by the American Diabetes
Association (2007).
We performed LC-MS/MS metabolic proﬁling of the OGTT
time course in MACS subjects. Out of the 191 metabolites
monitored byour platform, 97 weredetected in at least 80% of
subjects in all time points (Figure 1B). The levels of 21
metabolites changed signiﬁcantly (Po0.001) from the fasting
levels and were also signiﬁcantly (Po0.05) different when
compared to the response to water (Figure 1C). These 21
signiﬁcantly altered metabolites span pathways previously
studied in the context of glucose homeostasis, as well as some
never linked to this program.
Table I Demographic and clinical characteristics of human subjects
Clinical study MACS FOS
Group Glucose
a (n=22) Water
b (n=7) FOS-NGT (n=25) FOS-IGT (n=25)
Age (years) 23±3 (18–30) 24±4 (20–30) 45±3 (40–49) 46±3 (40–50)
Gender 9 women, 13 men 3 women, 4 men 13 women, 12 men 13 women, 12 men
Ancestry Wh: 9; As: 6; Un: 7 Wh: 3; Aa: 1; As: 1; Un: 2 Wh: 25 Wh: 25
BMI 22.4±2.1 (18.3–26.9) 22.1±2.7 (17.8–26.0) 24.6±3.4 (19.0–31.5) 26.8±4.8 (18.8–41.2)
Fasting glucose (mg/100ml) 78±5 (71–90) 77±7 (70–86) 89±6 (76–100) 100±9 (87–115)
120min glucose (mg/100ml) 86±16 (66–119) 80±9 (71–92) 88±21 (43–122) 153±12 (140–180)
Fasting insulin (mIU/ml) 4.6±2.9 (2.8–14.2) 3.6±0.7 (2.8–4.8) 4.2±2.7 (1.0–10.7) 10.3±8.1 (1.0–25.7)
120min insulin (mIU/ml) 18.1±16.5 (3.0–75.9) 3.6±1.0 (2.9–5.5) 29.7±20.5 (1.0–93.3) 102.8±51.8 (35.0–202.3)
IGT/NGT
c 0/22 NA 0/25 25/0
Abbreviations: MACS, Metabolic Abnormalities in College Students, conducted at MIT Clinical Research Center; FOS, Framingham Offspring Study; BMI, body mass
index. Ancestry abbreviations: Aa, African American; As, Asian; Un, unknown; Wh, White.
Quantitative variables are expressed as mean±s.d. (range).
aSubjects ingesting glucose (OGTT).
bSubjects ingesting water (control).
cNumber of subjects in each glucose tolerance category. IGT, impaired glucose tolerance (American Diabetes Association, 2007); NGT, normal glucose tolerance.
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samples from an independent cohort. The 2-h time point has
clinical signiﬁcance, and can aid in the diagnosis of impaired
glucose tolerance and diabetes (American Diabetes Associa-
tion, 2007). FOS-NGT (Table I) is a group of individuals with
normal glucose tolerance, derived from the Framingham
Offspring Study (Kannel et al, 1979). This group is similar to
MACS in size, gender composition, and glucose tolerance, but
theseindividualsareapproximately20yearsolderanddifferin
their ancestry (Table I). Of the 21 metabolites displaying
signiﬁcant change in MACS at any time point during OGTT
(Figure 1C), the levels of 20 (glucose excluded) remained
signiﬁcantly (Po0.05) altered at the 2-h time point. In total,
18 of these 20 metabolite changes replicated signiﬁcantly
(Po0.05) and in the same direction in FOS-NGT (Figure 2).
The remaining two metabolites, malate and arginine, fell
below our signiﬁcance threshold. We have thus identiﬁed 18
plasma metabolites exhibiting highly reproducible and likely
robust responses to glucose ingestion in healthy individuals.
Metabolic proﬁling reveals novel biochemical
changes during the OGTT
The systematic proﬁling approach has enabled us to identify a
number of plasma metabolites, not previously associated with
glucose homeostasis, that change reproducibly in response to
an oral glucose challenge. Perhaps most striking were the
observed changes in bile acids. The levels of three bile acids—
glycocholic acid, glycochenodeoxycholic acid and tauroche-
nodeoxycholic acid—more than doubled during the ﬁrst
30min after glucose ingestion, and remained elevated for the
entire 2h (Figure 3A). Water ingestion produced a smaller
increase in bile acids, which was not sustained beyond the
30min time point. All three compounds are primary bile acids
conjugated to glycine or taurine.
Thelevelsofcitrullineandornithine,twonon-proteinogenic
amino acids that participate in hepatic urea synthesis,
decreased by 35 and 29%, respectively during the 2-h test
(Figure 3B). Gluconeogenesis from amino acids (primarily
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hepatic glucose output after an overnight fast (Felig, 1975), is
coupled to urea synthesis (Devlin, 2002). The decreases in
citrulline and ornithine may thus be associated with the
reduction in gluconeogenesis and urea synthesis following
glucose ingestion.
Hypoxanthine, a purine base generated from degradation of
adenine and guanine nucleotides, decreased in MACS by 39%
within 2h of glucose ingestion (Figure 3C), and this pattern
was replicated in FOS-NGT. Xanthine, a purine base generated
from hypoxanthine by oxidation, also decreased in both
groups (MACS:  9%, Po0.05; FOS-NGT:  41%, Po10
 4).
Thedecreasesinhypoxanthineandxanthinemaybeexplained
byacombinationofattenuatedreleaseandaccelerateduptake.
Hypoxanthine taken up by tissues can support nucleotide
biosynthesis through the purine salvage pathway (Mateos
et al, 1987; Yamaoka et al, 1997) and may also be indicative of
a switch from catabolism to anabolism of nucleic acids,
analogous to the simultaneous transitions in fat and protein
metabolism.
Interestingly, hippuric acid increased by over 1000% during
the ﬁrst 30min and decreased gradually thereafter. Most likely
this response is not related to glucose, but rather reﬂects the
presence of the preservative benzoic acid, a precursor of
hippuricacid(KubotaandIshizaki,1991),foundintheglucose
beverage used for OGTT (see Materials and methods).
Changes in plasma metabolites span four arms
of insulin action
Much of the biochemical response to glucose ingestion, which
we studied in an unbiased way, can be attributed to the broad
actions of insulin (Figure 4A). Speciﬁcally, we have detected
an increase in lactate and decreases in glycerol, b-hydro-
xybutyrate and amino acids. These metabolite changes
correspond to the stimulation of glucose metabolism and to
the suppression of lipolysis, ketogenesis, and proteolysis (as
well as stimulation of amino-acid uptake), all of which are
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et al, 1986).
Our method captured the temporal relationship between
glucose and intermediates of glycolysis (Figure 4B). Speciﬁ-
cally, the increase in pyruvate, lactate, and alanine occurred
between 30 and 60min, lagging B30min behind the glucose
rise, consistent with previous reports (Kelley et al, 1988).
Interestingly, the kinetics of malate, an intermediate in the
Krebs cycle, closely resembled the kinetics of lactate and
pyruvate, suggesting that a fraction of the pyruvate formed
through glycolysis was carboxylated to generate malate
through oxaloacetate. To our knowledge, elevation of plasma
malate levels due to glucose ingestion has not been previously
reported.
To gain insight into the kinetics of insulin action, we
compared temporal patterns for metabolites indicative of the
suppression of fat and protein catabolism. The levels of
glycerol, b-hydroxybutyrate, and multiple amino acids all
declined after glucose ingestion, but the kinetic pattern of
glyceroland b-hydroxybutyratewas remarkablydifferent from
amino acids (Figure 4C). Over the 2h, the decrease in glycerol
and b-hydroxybutyrate levels was 57 and 55%, respectively,
whereas the drop in amino acids was moderate (between 14
and 36%). The branched-chain amino acids leucine/isoleu-
cine (indistinguishable by our method), for example, de-
creased by 33%. Interestingly, the time to reach half-maximal
decrease in the amino acids (50–72min) was greater than in
b-hydroxybutyrate (42min) and glycerol (30min). Moreover,
the inter-individual variance in metabolite levels shrunk
dramatically over the 2h in glycerol and b-hydroxybutyrate
(84 and 95% reduction of inter-quartile range, respectively),
whereas in amino acids the maximal reduction was 53%.
These ﬁndings suggest that the suppression of lipolysis and
ketogenesis is more sensitive to the action of insulin compared
to suppression of protein catabolism.
Metabolite excursions reﬂect multiple dimensions
of insulin sensitivity
Having identiﬁed 18 metabolites that exhibit robust 2-h
excursions, we were interested in determining whether the
metabolites might be useful in understanding insulin sensi-
tivity.Insulinsensitivityistraditionallydeﬁnedastheabilityof
insulintopromotetheuptakeofglucoseintoperipheraltissues
such as skeletal muscle and fat or to suppress gluconeogenesis
in the liver. Adecline of insulin sensitivity is one of the earliest
signs of type 2 diabetes mellitus (T2DM). This decline is often
manifest as elevated levels of fasting insulin, which is strongly
correlated with measurements of insulin sensitivity (Hanson
et al, 2000). Considering that several metabolic processes
taking place following glucose ingestion are mediated by
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reﬂected not only by changes in glucose but also by the OGTT
response of multiple other metabolites. Because our initial
studies were focused on normal, healthy individuals spanning
a narrow range of fasting insulin levels, we performed a third
analysis on a group of individuals with impaired glucose
tolerance from the Framingham Offspring Study, FOS-IGT,
who spanned a broaderrange of fasting insulin concentrations
(Table I).
First, to systematically evaluate the relationship between
individual metabolite excursions and fasting insulin, we
performed linear regression of the fasting insulin concentra-
tion on each of the 18 2-h excursions. Out of the 18, 6 showed
a statistically signiﬁcant (Po0.05) correlation with fasting
insulin, and included the excursions in lactate, b-hydroxybu-
tyrate, amino acids (leucine/isoleucine, valine, and methio-
nine), and a bile acid (GCDCA) (Table II). Taken together with
the glycerol excursion, which scored (P¼0.07) slightly below
the signiﬁcance threshold, the response of four distinct insulin
action markers correlated with fasting insulin (Figure 5A).
Individuals with high fasting insulin exhibited a blunted
excursion in all seven metabolites: they had a smaller change
both in increasing metabolites (lactate and GCDCA) and in
decreasing metabolites (the other ﬁve). Notably, the glucose
excursion was not correlated with fasting insulin (P¼0.20).
These ﬁndings suggest that resistance to the action of insulin
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Figure 5 Correlation between fasting insulin and 2-h metabolite changes in individuals with impaired glucose tolerance (FOS-IGT). (A) 2-h changes in markers of
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Table II Regression models relating fasting insulin to 2-h metabolite change
in individuals with impaired glucose tolerance (FOS-IGT)
Predictor(s) R
2
adj P-value Prediction
error
a
D
b Leucine/isoleucine 0.36 9E 4 6.65
D Valine 0.17 3E 2 7.74
D Lactate 0.16 3E 2 7.60
D Glycochenodeoxycholic acid 0.14 4E 2 7.86
D Methionine 0.14 4E 2 7.68
Db -Hydroxybutyrate 0.14 4E 2 7.90
D Leucine/isoleucine+D glycerol
c 0.54 7E 5 5.66
PLS
d 0.46 1E 4 6.89
BMI 0.33 1E 3 6.74
aThe prediction error is expressed as the root mean square error of prediction
(RMSEP), in micro-international units per milliliter insulin.
bD denotes log of the 2-h fold change of metabolite levels.
cA bivariate model consisting of the 2-h changes in leucine/isoleucine and in
glycerol.
dPartial least squares based on changes in the 18 validated metabolites.
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the metabolite response to OGTT.
Next, we sought to determine whether a combination of two
or more of the 18 metabolite excursions might be more
predictive of insulin sensitivity than are individual excursions.
We used forward stepwise linear regression to discover an
optimallinearmodel relating 2-h metabolite changesto fasting
insulin levels.The top regression model identiﬁed consisted of
the excursions in Leu/Ile and glycerol (R
2
adj¼0.54, P¼0.0001).
In this bivariate model, the independent contribution from
each metabolite excursion was signiﬁcant (Leu/Ile:
P¼8 10
 5, glycerol: P¼4 10
 3), and the two predictors
were not correlated with each other (P¼0.6). The Leu/Ile–
glycerol model predicted fasting insulin levels better than
any individual metabolite excursion (Table II). BMI, which is
known to be a strong predictor of fasting insulin, was less
predictive than the bivariate model. Notably, the explanatory
power of the Leu/Ile and glycerol excursions was signiﬁcant
even after controlling for BMI (P¼2 10
 3 and 3 10
 3,
respectively). A graphical representation of the Leu/Ile–gly-
cerol model (Figure 5B) demonstrates that some individuals
with high fasting insulin exhibit a blunted decline in glycerol,
whereas others exhibit a blunted decline in Leu/Ile.
To identify linear combinations of all 18 metabolite
excursions that might be predictive of fasting insulin, we used
partial least squares (PLS). PLS is a multivariate method that
ﬁnds orthogonal linear combinations (called components) of
the original predictor variables (here, metabolite excursions),
which are most correlated with a response variable (here,
fasting insulin). To determine how many components should
be included in the model while keeping it general, the model is
tested on new data (a method called cross-validation). In the
current PLS model, the smallest prediction error was achieved
with the ﬁrst component alone (Table II), and a similar error
was obtained with the ﬁrst two components. Interestingly, the
Leu/Ile excursion had the largest coefﬁcient in the ﬁrst
component, whereas the glycerol excursion contributed
primarily to the second. The prediction error of the bivariate
model consisting of the excursions in Leu/Ile and glycerol was
lower than the PLS model error (Table II). These ﬁndings
indicate that the excursions in Leu/Ile and glycerol are
sufﬁcient to capture the correlation of 2-h metabolite changes
with fasting insulin.
In summary, we have used a univariate approach as well as
two multivariate approaches to investigate the correlates of
insulin sensitivity. Remarkably, all three methods spotlighted
the change in Leu/Ile and change in glycerol as being
predictive of fasting insulin. Changes in these two metabolites
are blunted in insulin-resistant individuals during the OGTT.
Discussion
In the current study, we have applied metabolic proﬁling to
investigate the kinetics of human plasma biochemicals in
response to an oral glucose challenge. To our knowledge, this
is the ﬁrst study to apply a proﬁling technology to characterize
this physiologic program. The systematic approach we have
taken has enabled us to recapitulate virtually all known
polar metabolite changes associated with the OGTT, while
spotlighting some pathways never linked to this program.
Importantly, simultaneous measurement of multiple metabo-
lites made it possible to explore connections among metabolic
pathways, providing novel insights into normal physiology
and disease.
One of the most surprising ﬁndings of this investigation is
the dramatic increase in bile acid levels following glucose
ingestion. In response to eating, the gallbladder contracts and
releases bile into the intestines. Bile acids are then absorbed
and travel through the portal vein back to the liver, where the
enterohepatic cycle completes. Although the uptake of bile
acids to the liver is fairly efﬁcient, a constant fraction
(10–30%) reaches the systemic circulation (Angelin et al,
1982). In a previous investigation, human subjects ingesting a
standard liquid meal containing fat and protein exhibited an
increase of 320–330% in individual serum bile acids (De
Barros et al, 1982). In the current study, we found that
ingesting glucose alone elicits a bile acid response of similar
magnitude (Figure 3A), which is sustained for 2h. Our ﬁnding
is supported by previous work showing that glucose ingestion
can increase the plasma concentration of cholecystokinin, a
hormone signaling the gallbladder to contract (Liddle et al,
1985). Interestingly, a recent investigation has shown that bile
acids are a signal for fat and muscle cells to increase their
energy expenditure through activation of thyroid hormone
(Watanabe et al, 2006). Given these ﬁndings, and our
observation of bile acid release following glucose ingestion,
we tested the hypothesis that bile acids inﬂuence peripheral
glucose uptake. We could not detect an effect of bile acids on
basal or insulin-stimulated glucose uptake, however, in
cultured adipocytes (data not shown). At present, the
physiologic role of sustained bile acid release following
glucose ingestion is unknown.
Although insulin resistance is traditionally deﬁned as the
reduced ability of insulin to promote glucose uptake or as the
impaired suppression of gluconeogenesis, resistance can
emerge in other insulin-dependent processes. In prior studies,
for example, inadequate suppression of lipolysis wasobserved
in women with a history of gestational diabetes (Chan et al,
1992), and an elevated proteolysis rate wasseen in individuals
with HIV-associated insulin resistance (Reeds et al, 2006). In
obesity, manifestations of insulin resistance include elevated
rates of lipolysis (Robertson et al, 1991) and proteolysis
(Jensen and Haymond, 1991; Luzi et al, 1996). We have used
metabolic proﬁling to monitor insulin action across multiple
axes (Figure 4A), and with markers of each axis in hand, were
able to detect kinetic differences between them. In healthy
individuals, insulin’s suppression of lipolysis and ketogenesis
is rapidcomparedto its suppression of proteolysis (Figure 4C),
consistent with the different concentrations of insulin required
to inhibit each of these processes (Fukagawa et al, 1985;
Nurjhan et al, 1986). Such differences in the activation
thresholds of metabolic pathways could be contributing to
the diversity in the clinical presentation of insulin resistance.
Mouse models of insulin-resistant T2DM provide another
example for inter-pathway differences in insulin sensitivity: in
the livers of these mice, gluconeogenesis is resistant to
suppression by insulin, whereas lipogenesis is responsive,
resulting in hyperglycemia and hypertriglyceridemia (Brown
and Goldstein, 2008). Collectively, these observations
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could lead to selectivity in insulin sensitivity and contribute
to pathogenesis.
Our study demonstrates that an individual’s ‘insulin
response proﬁle’, namely, the vector of sensitivities to insulin
action along multiple physiologic axes, can be revealed by
metabolite excursions in response to a glucose challenge.
Speciﬁcally, we have shown that excursions in Leu/Ile and
glycerol,reﬂectingthesensitivityofproteolysisandlipolysisto
the action of insulin, are jointly predictive of fasting insulin,
with each of the two excursions offering complementary and
signiﬁcant explanatory power (Figure 5B). These ﬁndings
demonstrate that in two individuals, different axes could be
responsible for the same elevation of fasting insulin, and
simultaneous measurement of metabolites can distinguish
between the two conditions. Monitoring the response to
glucose ingestion across multiple axes in larger, prospective
clinical studies of pre-diabetics could establish links between
insulin sensitivity proﬁles and disease progression, thus
helping to predict future diabetes and its complications as
well as to guide therapeutic interventions.
Materials and methods
Human subjects
MACS
Subjects were young adults in the age range of 18–30 years who
volunteeredforthestudyduringtheacademicyear2006–2007.Control
subjects (ingesting water instead of glucose solution) were assigned at
random, balancing gender. Metabolic proﬁling analysis was limited to
those subjects with normal fasting glucose concentrations (below
100mg/100ml) and normal glucose tolerance (2-h glucose concentra-
tion below 140mg/100ml).
FOS
Subjects were selected at random (balancing gender) from among all
participants in the ﬁfth FOS examination cycle (1991–1995) aged 40–
49 years who had no diabetes mellitus, hypertension or prior
cardiovascular disease. Additional selection criteria for FOS-NGTwere
normal fasting glucose concentrations and normal glucose tolerance.
Additional selection criterion for FOS-IGT was impaired glucose
tolerance (2-h glucose concentration between 140 and 199mg/
100ml).
Table I lists demographic and metabolic characteristics of cohorts
from the MACS and FOS studies.
OGTT
MACS
Subjects were admitted to the Massachusetts Institute of Technology
Clinical Research Center (CRC) after a 10h overnight fast. An
intravenous catheter was inserted into an antecubital vein or a wrist
vein and fasting samples were drawn. Next, each subject ingested a
glucose solution (Trutol, 75g in 296ml; NERL Diagnostics, East
Providence, RI; contains citric acid and sodium benzoate) or an
identical volume of bottled water (Poland Spring Water, Wilkes Barre,
PA) over a 5-min period. Additional blood samples were drawn from
the inserted catheter 30, 60, 90 and 120min after ingestion. Subjects
remained at rest throughout the test. The study protocol was approved
bythe MITCommitteeon the Useof Humans as Experimental Subjects
and the CRC Scientiﬁc Advisory Committee.
FOS
Subjects underwent an OGTTas part of the FOS (Arnlov et al, 2005).
After 12h overnight fast, subjects ingested 75g glucose in solution.
Bloodsamplesweredrawnfastingand120minafterglucoseingestion.
The study protocol was approved by the Institutional Review Board at
Boston Medical Center.
Metabolic proﬁling
Blood processing
Blood was drawn into EDTA-coated tubes. In MACS, blood was
centrifugedfor10minat61Cand2000g.InFOS,bloodwascentrifuged
for 30min at 41C and 1950g. Plasma samples were stored at  801C.
Sample preparation and analysis
Plasma samples were thawed gradually, and 165ml from each sample
was mixed with 250ml of ethanol solution (80% ethanol, 19.9% H2O,
and 0.1% formic acid) to precipitate out proteins. After 2h at 41C, the
samples were centrifuged at 15000g for 15min, and 300ml of the
supernatant was extracted and evaporated under nitrogen. Samples
were reconstituted in 60ml HPLC-grade water, and separated on three
different HPLC columns. The columns were connected in parallel to a
triple quadrupole mass spectrometer (4000 Q Trap; Applied Biosys-
tems) operated in selected reaction-monitoring mode. Each metabolite
was identiﬁed by a combination of chromatographic retention time,
precursor ion mass, and product ion mass. Metabolite quantiﬁcation
was performed by integrating the peak areas of product ions using
MultiQuant software (Applied Biosystems). Additional details on
the analytical methodology are provided in the Supplementary
information.
Glucose and insulin
Plasma glucose concentration was measured with a hexokinase assay
(MACS: Quest Diagnostics,Cambridge, MA;FOS:Abbott Laboratories,
IL). Insulin international units were determined using a radio-
immunoassay (Diagnostic Product Corporation, Los Angeles, CA). In
MACS, sodium ﬂuoride–potassium oxalate blood tubes were used for
glucose analysis, and blood tubes with no additive were used for
insulin analysis.
Statistical analysis
Univariate analysis
The signiﬁcance of a change from the fasting metabolite level was
calculated using the paired Wilcoxon signed-rank test. The signiﬁ-
cance of a difference between glucose and water ingestion was
calculatedusingtheunpairedWilcoxonranksumtest.WhereallB100
detected metabolites were tested, a signiﬁcance threshold of a¼0.001
was used to account for multiple hypotheses testing. A threshold of
a¼0.05 was used elsewhere.
Multivariate analysis and linear regression
Two multivariate approaches were used to identify combinations of
2-h metabolite changes predictive of fasting insulin: forward stepwise
linear regression and PLS regression. In stepwise linear regression, the
signiﬁcance threshold for addition of a variable to the model was
a¼0.05.InPLSregression,thenumberofcomponentstoincludeinthe
model was determined using leave-one-out cross-validation. The
prediction error of a model was expressed as the root mean square
error of prediction. Missing values (less than 2% of the data) were
replaced with the mean of present values.
Statistical analysis was performed in R (The R Project for Statistical
Computing) and in Matlab (The MathWorks Inc.).
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Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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